Literature DB >> 10217392

SSRI antidepressant drug use patterns in the naturalistic setting: a multivariate analysis.

T R Hylan1, W H Crown, L Meneades, J H Heiligenstein, C A Melfi, T W Croghan, D P Buesching.   

Abstract

BACKGROUND: The study of the duration and pattern of antidepressant use in actual clinical practice can provide important insights into how antidepressant prescribing patterns compare with recommended depression treatment guidelines.
OBJECTIVE: The purpose of this study, using data available from depressed outpatients in the United States, is to assess the effects of initial SSRI antidepressant selection on the subsequent pattern and duration of antidepressant use. RESEARCH
DESIGN: Multiple logistic regression analysis of data from a large prescription and medical claims database (MarketScan) for the years 1993 and 1994 were used to estimate the determinants of antidepressant drug use patterns for 1,034 patients with a "new" episode of antidepressant therapy who were prescribed one of three most often prescribed selective serotonin reuptake inhibitors (SSRIs), paroxetine, sertraline, or fluoxetine.
RESULTS: Patients initiating therapy on sertraline or paroxetine were less likely than patients initiating therapy on fluoxetine to have four or more prescriptions of their initial antidepressant within the first 6 months.
CONCLUSIONS: The findings suggest that antidepressant selection is an important determinant of the initial duration and pattern of antidepressant use which is consistent with current recommended depression treatment guidelines.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10217392     DOI: 10.1097/00005650-199904001-00007

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  5 in total

1.  Current issues in the economics of depression management.

Authors:  D Thompson; E Richardson
Journal:  Curr Psychiatry Rep       Date:  1999-12       Impact factor: 5.285

Review 2.  Fluoxetine. A pharmacoeconomic review of its use in depression.

Authors:  M I Wilde; P Benfield
Journal:  Pharmacoeconomics       Date:  1998-05       Impact factor: 4.981

Review 3.  The need for an iterative process for assessing economic outcomes associated with SSRIs.

Authors:  T L Skaer; D A Sclar; L M Robison; R S Galin
Journal:  Pharmacoeconomics       Date:  2000-09       Impact factor: 4.981

4.  Expenditures associated with dose titration at initiation of therapy in patients with major depressive disorder: a retrospective analysis of a large managed care claims database.

Authors:  Fabian Camacho; Meg C Kong; David V Sheehan; Rajesh Balkrishnan
Journal:  P T       Date:  2010-08

5.  Prior authorization for antidepressants in Medicaid: effects among disabled dual enrollees.

Authors:  Alyce S Adams; Fang Zhang; Robert F LeCates; Amy Johnson Graves; Dennis Ross-Degnan; Daniel Gilden; Thomas J McLaughlin; Christine Lu; Connie M Trinacty; Stephen B Soumerai
Journal:  Arch Intern Med       Date:  2009-04-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.